Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis SAN

Aristocrat - 25 or more consecutive years of dividend increases

Max Ratio

6.17

Dividend Yield

4.64 %

5Y Dividend Growth

23.00 %

Consecutive Years

29 years

5Y Average Payout Ratio

62.78 %

Dividend History SAN

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 4.64 %
Consecutive Years 29
Forward Annual Dividend 3.92 EUR
Consistent Years 34
Dividend CAGR 3Y 5.71 %
Continuous Dividends
Dividend CAGR 5Y 4.25 %
Payout Ratio TTM 51.83 %
Dividend CAGR 10Y 3.05 %
Ex Dividend Date 05/12/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth SAN

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin SAN

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income SAN

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM SAN

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio SAN

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Sanofi SA SAN

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself SAN

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 16.14
Forward PE 10.14
Enterprise Value Revenue 2.43
Price Sales TTM 2.24
Enterprise Value EBITDA 8.80
Price Book MRQ 1.42

Sanofi SA Dividends: 4.64 % Yield, History, Payment Schedule

SAN
Current price
84.57 EUR -0.73 EUR (-0.86%)
Last closed 85.64 EUR
ISIN FR0000120578
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Euronext Paris
Capitalization 103 220 377 261 EUR
Yield for 12 month -7.88 %
1Y
3Y
5Y
10Y
15Y
SAN
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+44 378 484 794 EUR

Last Year

+41 194 850 097 EUR

Current Quarter

+13 197 503 607 EUR

Last Quarter

+10 757 418 468 EUR

Current Year

+31 155 928 979 EUR

Last Year

+28 549 497 173 EUR

Current Quarter

+9 778 378 147 EUR

Last Quarter

+7 759 170 116 EUR
EBITDA 12 359 757 872 EUR
Operating Margin TTM 28.73 %
Price to Earnings 16.14
Return On Assets TTM 4.61 %
PEG Ratio 0.76
Return On Equity TTM 8.84 %
Wall Street Target Price 91.10 EUR
Revenue TTM 46 026 919 942 EUR
Book Value 60.27 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -7.00 %
Dividend Yield 4.64 %
Gross Profit TTM 33 141 067 032 EUR
Earnings per share 5.25 EUR
Diluted Eps TTM 5.25 EUR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY 2.40 %
Profit Margin 19.84 %

Technical Indicators SAN

For 52 Weeks

76.31 EUR 106.42 EUR
50 Day MA 86.01 EUR
Shares Short Prior Month
200 Day MA 88.93 EUR
Short Ratio
Shares Short
Short Percent